Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (288)	11/4/2004 5:50:34 AM
From: Icebrg	of 946

>>I guess you have to look at when the article was first submitted>> Yes, that is clear. However it does appear as if there is a keen interest from CTIC's side to see this type of discussions now. Yesterday there appeared a one-hour CME-session at Medscape featuring Drs Lander and Cella. "PS2 Patients With Advanced NSCLC: Challenges and Therapeutic Options (Archived Web Conference)" medscape.com The study is "independently" financed by Cell Therapeutics. It appears to me that CTIC's has at least high hopes, that the results from Stellar 3 (and 4) will be favorable. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next